newsfilter
← Latest News
GlobeNewswire·

Celcuity Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Reported statistically significant and clinically meaningful improvement in both primary endpoints from the PIK3CA wild-type cohort of the Phase 3 VIKTORIA-1 trialHazard ratios and improvements in median progression-free